[Long-term treatment of open-angle glaucoma with bupranolol eye drops (author's transl)].
In this study we examined the effect of Bupranolol eye drops on 10 patients with open-angle glaucoma. Treatment extended over six months. Bupranolol eye drops lowered intraocular pressure by about 15% over a prolonged period. Some patients needed treatment in combination with miotics. Visual acuity and visual fields remained constant. As a rule, Bupranolol was tolerated well by the patients
D000328:Adult; D000368:Aged; D002046:Bupranolol / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D008916:Miotics / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000627:therapeutic use*
D008916:Miotics; D009883:Ophthalmic Solutions; D011412:Propanolamines; D002046:Bupranolol
Langzeitbehandlung des Weitwinkelglaukoms mit Bupranolol.